Summit Wealth Partners LLC Has $852,000 Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Summit Wealth Partners LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 14.2% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,684 shares of the healthcare conglomerate’s stock after purchasing an additional 209 shares during the quarter. Summit Wealth Partners LLC’s holdings in UnitedHealth Group were worth $852,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in UNH. Vanderbilt University boosted its stake in UnitedHealth Group by 1.7% in the 4th quarter. Vanderbilt University now owns 7,867 shares of the healthcare conglomerate’s stock valued at $3,980,000 after purchasing an additional 131 shares during the period. Foguth Wealth Management LLC. raised its holdings in UnitedHealth Group by 27.7% in the 4th quarter. Foguth Wealth Management LLC. now owns 521 shares of the healthcare conglomerate’s stock valued at $277,000 after acquiring an additional 113 shares in the last quarter. Clayton Financial Group LLC raised its holdings in shares of UnitedHealth Group by 80.0% during the 4th quarter. Clayton Financial Group LLC now owns 3,970 shares of the healthcare conglomerate’s stock worth $2,009,000 after buying an additional 1,765 shares in the last quarter. Choreo LLC increased its holdings in UnitedHealth Group by 8.7% in the 4th quarter. Choreo LLC now owns 39,204 shares of the healthcare conglomerate’s stock worth $19,882,000 after purchasing an additional 3,132 shares in the last quarter. Finally, Nvwm LLC increased its holdings in UnitedHealth Group by 0.9% in the 4th quarter. Nvwm LLC now owns 4,101 shares of the healthcare conglomerate’s stock worth $2,075,000 after purchasing an additional 36 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 1.1 %

Shares of UNH stock opened at $539.50 on Thursday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The business has a 50-day moving average price of $533.81 and a two-hundred day moving average price of $564.94. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The firm has a market cap of $496.49 billion, a P/E ratio of 34.81, a price-to-earnings-growth ratio of 1.48 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the previous year, the company posted $5.83 EPS. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.63 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on UNH shares. Morgan Stanley reduced their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Wells Fargo & Company reduced their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Cantor Fitzgerald reissued an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Deutsche Bank Aktiengesellschaft raised their target price on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Finally, Oppenheimer raised their target price on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and an average price target of $629.32.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.